Marinus Verwijs's Insider Trades & SAST Disclosures

Marinus Verwijs's most recent trade in Jade Biosciences Inc was a trade of 10,600 Common Stock done at an average price of $14.6 . Disclosure was reported to the exchange on June 14, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.59 per share. 14 Jun 2024 10,600 10,600 - 14.6 154,654 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jun 2024 10,600 68,800 - - Stock Option (Right to Buy)
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Sale of securities on an exchange or to another person at price $ 25.00 per share. 14 Jun 2024 10,600 0 - 25 265,000 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Sale of securities on an exchange or to another person at price $ 21.02 per share. 02 May 2024 1,981 0 - 21.0 41,631 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Apr 2024 5,300 79,400 - - Stock Option (Right to Buy)
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.59 per share. 01 Apr 2024 5,300 5,300 - 14.6 77,327 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Sale of securities on an exchange or to another person at price $ 28.87 per share. 01 Apr 2024 3,796 1,504 - 28.9 109,579 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Sale of securities on an exchange or to another person at price $ 30.00 per share. 01 Apr 2024 1,504 0 - 30.0 45,118 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.59 per share. 19 Mar 2024 5,300 5,300 - 14.6 77,327 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Mar 2024 5,300 84,700 - - Stock Option (Right to Buy)
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Sale of securities on an exchange or to another person at price $ 26.46 per share. 19 Mar 2024 2,764 0 - 26.5 73,124 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNICAL OFFICER Sale of securities on an exchange or to another person at price $ 25.68 per share. 19 Mar 2024 2,536 2,764 - 25.7 65,119 Common Stock
Jade Biosciences Inc
Marinus Verwijs CHIEF TECHNOLOGY OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2024 66,586 66,586 - - Stock Option (Right to Buy)
Jade Biosciences Inc
Marinus Verwijs SENIOR VICE PRESIDENT, CMC Sale of securities on an exchange or to another person at price $ 20.79 per share. 03 May 2023 759 0 - 20.8 15,779 Common Stock
Jade Biosciences Inc
Marinus Verwijs SENIOR VICE PRESIDENT, CMC Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2023 62,000 62,000 - - Stock Option (Right to Buy)
Jade Biosciences Inc
Marinus Verwijs SENIOR VICE PRESIDENT, CMC Sale of securities on an exchange or to another person at price $ 18.89 per share. 02 Nov 2022 1,130 0 - 18.9 21,346 Common Stock
Jade Biosciences Inc
Marinus Verwijs Senior Vice President, CMC Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Mar 2022 90,000 90,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades